PubMed · 1994 · 522 citations · 20 references
MedicineGeneticsMolecular GeneticsCancer GeneticsMolecular OncologyOncogenesCancer Molecular DiagnosticsMalignant NeoplasmsOncogene AmplificationOncogene MutationsPancreatic CancerRas Family OncogenesAllele-specific Oligonucleotide Polymerase Chain ReactionCellular OncogenesCystic Fibrosis GeneticsPlasma GenotypingPrognostic Tumor MarkersTumor Mutation Detection
Healthy individuals have soluble (extracellular) DNA in their blood, and increased amounts are present in cancer patients. Here we report the detection of specific sequences of the cystic fibrosis and K-ras genes in plasma DNA from normal donors by amplification with the polymerase chain reaction. In addition, mutated K-ras sequences are identified by polymerase chain reaction utilizing allele-specific primers in the plasma or serum from three patients with pancreatic carcinoma that contain mutated K-ras genes. The mutations are confirmed by direct sequencing. These results indicate that sequences of single-copy genes can be identified in normal plasma and that the sequences of mutated oncogenes can be detected and identified with allele-specific amplification by polymerase chain reaction in plasma or serum from patients with malignant tumors containing identical mutated genes. Mutated oncogenes in plasma and serum may represent tumor markers that could be useful for diagnosis, determining response to treatment, and predicting prognosis.
20
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Bat-Sheva Kerem, Johanna M. Rommens, Janet A. Buchanan et al. · Science · 1989 · 4.1K citations
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Concepción Almoguera, Darryl Shibata, Kathleen Forrester et al. · Cell · 1988 · 2.1K citations
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
Maurice Stroun, Philippe Anker, P Maurice et al. · Oncology · 2009 · 724 citations